Table 3 Etiology of renal disease, classes of antihypertensive medications and proteinuria
|  | OBP < 140 and <90 and HBP < 135 and <85 | OBP ≥140 and/or ≥90 and HBP≥135 and/or ≥85 | P |
|---|---|---|---|
N | 15 | 34 | Â |
Etiology of renal disease. N (%) | Â | Â | Â |
Vascular disease | 0 | 1 (3) | 1.00 |
Glomerulonephritis | 4 (26.7) | 11 (33.3) | 0.75 |
Polycystic kidney disease | 4 (26.7) | 6 (18.2) | 0.47 |
Diabetic nephropathy | 1 (6.7) | 4 (12.1) | 1.00 |
Tubulo intertitial disease | 1 (6.7) | 6 (18.2) | 0.22 |
Unknown | 5 (33.3) | 5 (15.2) | 0.13 |
Antihypertensive drugs N (%) | Â | Â | Â |
Diuretics | 4 (26.7) | 10 (29) | 1.00 |
Thiazide and loop | 3 | 9 | 0.73 |
K-sparing | 1 | 1 | 0.51 |
Beta-blockers | 9 (60) | 21 (61.8) | 1.00 |
Calcium-channel blockers | 9 (60) | 18 (53) | 0.76 |
Angiotensin converting enzyme inhibitors | 5 (33.3) | 11 (32.3) | 1.00 |
Angiotensin receptor blockers | 4 (26.7) | 5 (14.7) | 0.43 |
Centrally acting sympathicolytics | 1 (6.7) | 8 (23.5) | 0.24 |
Proteinuria (mg/g creatinine) | Â | Â | Â |
<40 | 3 (21.4) | 9 (26.5) | 0.73 |
40–200 | 10 (71.4) | 19 (55.9) | 0.35 |
>200 | 2 (13.3) | 6 (17.6) | 1.00 |